United States Analgesics Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Analgesics Market reached US$ 56.02 billion in 2024 and is expected to reach US$ 80.50 billion by 2032, growing at a CAGR of 4.1% during the forecast period 2025-2032, according to DataM Intelligence report.

Key Development:

United States: Recent Industry Developments

✅ In July 2025, Eli Lilly announced the launch of its next-generation non-opioid analgesic candidate in Phase III trials.The therapy aims to address chronic pain while minimizing dependency risks.The development reflects growing U.S. focus on safer pain management alternatives.

✅ In June 2025, Pfizer invested $200 million into expanding its analgesics R&D pipeline.The funding supports novel small-molecule and biologic pain therapies with an emphasis on neuropathic pain conditions.Clinical studies are expected to accelerate from 2026.

✅ In May 2025, Johnson & Johnson introduced a new OTC acetaminophen formulation with extended-release technology.The product is designed for improved patient compliance and longer-lasting pain relief.The innovation strengthens J&J's consumer healthcare portfolio in analgesics.

Japan: Recent Industry Developments

✅ In July 2025, Shionogi & Co. launched a next-generation nonsteroidal anti-inflammatory drug (NSAID) in domestic markets.The product targets musculoskeletal pain with a lower risk of gastrointestinal side effects.It positions Shionogi as a leader in safer pain relief solutions.

✅ In June 2025, Daiichi Sankyo announced a strategic partnership with Kyoto University to develop novel analgesics based on ion channel modulation.The collaboration focuses on innovative mechanisms for chronic pain management.Preclinical trials are currently underway.

✅ In May 2025, Takeda Pharmaceutical invested in advanced biologic-based analgesics targeting inflammatory pain disorders.The company aims to expand beyond traditional painkillers into precision medicine solutions.Development milestones are anticipated by late 2026.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/analgesics-market?sb

Analgesics are medications designed to relieve pain without causing loss of consciousness. They include non-opioid drugs (like acetaminophen), opioid drugs (like morphine), and combination formulations, used to manage acute, chronic, cancer-related, and surgical pain, improving patient comfort and quality of life.

Recent Mergers and Acquisitions

United States: Recent M&A in Analgesics

✅ In August 2025, PainReform Ltd. acquired a majority equity interest in LayerBio, a company developing OcuRingTM-K, an investigational non-opioid NSAID drug delivery system for postoperative pain control following cataract surgery. This strategic move positions PainReform in the $9 billion global cataract surgery market.

✅ In July 2025, Mira Pharmaceuticals provided an update on its planned acquisition of SKNY Pharmaceuticals. The SEC completed its review of the merger proxy without comment, allowing the company to proceed with shareholder approval and final steps toward closing the transaction. SKNY Pharmaceuticals is developing SKNY-1, an investigational therapy targeting obesity and nicotine addiction.

✅ In May 2025, Eli Lilly announced the acquisition of SiteOne Therapeutics for up to $1 billion. The deal includes SiteOne's Phase II-ready oral NaV1.8 inhibitor, STC-004, aimed at chronic pain conditions. This acquisition strengthens Lilly's non-opioid pain management pipeline.

Japan: Recent M&A in Analgesics

✅ In June 2025, Japanese pharmaceutical company Kyowa Kirin announced the acquisition of U.S.-based biopharma firm Argenx's pain management division. The deal aims to enhance Kyowa Kirin's portfolio with Argenx's novel pain therapeutics currently in clinical trials.

✅ In May 2025, Takeda Pharmaceutical Company finalized its acquisition of a majority stake in a Japanese biotech startup specializing in gene therapy for chronic pain disorders. This acquisition is part of Takeda's strategy to expand its pain management pipeline with innovative, long-term solutions.

Key Players:

=> Bayer AG, Teva Pharmaceuticals USA, Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin, Cipla, Sanofi, AdvaCare Pharma, Wellona Pharma, and Montage Laboratories Pvt. Ltd. among others.

Growth Forecast Projected:

The Global Analgesics Imaging Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Analgesics Imaging Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=analgesics-market

Key Segments:

➥ By Type: Non-opioid Analgesics, Opioid Analgesics, Compound Analgesics

➥ By Pain Type: Acute, Chronic

➥ By Application: Cancer Pain, Surgical Pain, Neuropathic Pain, Others

➥ By Route of Administration: Oral, Topical, Parenteral, Others

➥ By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

Regional Analysis for Analgesics Imaging Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Analgesics Imaging producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Analgesics Imaging revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/analgesics-market?sb

FAQ

What is the current size of the Analgesics Imaging Market?

A: In 2024, the Analgesics Imaging Market was valued at US$ 56.02 billion , reflecting its strong industry presence.

Q2: How large is the Analgesics Imaging Market expected to be by 2032?

A: By 2032, industry forecasts suggest the Analgesics Imaging Market will grow to around US$ 80.50 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Analgesics Imaging Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 4.1% during the forecast period from 2025 to 2032.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.